Patents by Inventor Lola Weiss

Lola Weiss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treating or preventing diabetes with cannabidiol
    Patent number: 8071641
    Abstract: Use of a cannabidiol for the manufacture of a medicament identified for the treatment or prevention of diabetes and/or insulitis.
    Type: Grant
    Filed: February 16, 2005
    Date of Patent: December 6, 2011
    Assignees: Yissum Research Development Company of the Hebrew University of Jerusalem, Hadsit Hadasit Medical Research Services and Development Ltd.
    Inventors: Lola Weiss, Michael Zeira, Raphael Mechoulam, Shimon Slavin, Ruth Gallily
  • THERAPEUTIC USES OF CANNABIDIOL COMPOUNDS
    Publication number: 20100158973
    Abstract: The present invention provides the use of a Cannabidiol (CBD) compound for the preparation of a pharmaceutical composition for treatment as well as for the prevention of at least one fundamental parameter affecting a vascular system selected from (a) the cardiovascular system; (b) the peripheral vascular system; or (c) a combination of (a) and (b); as well as pharmaceutical compositions and therapeutic methods for treating the above. A fundamental parameter may include blood/plasma lipid profile; atherosclerosis plaque load; size of heart scar; thickness of heart scar; and cardiac function in general. In accordance with a preferred embodiment the invention concerns treatment of heart scars as well as preventing the formation of heart scars.
    Type: Application
    Filed: March 13, 2007
    Publication date: June 24, 2010
    Applicant: HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LlIMITED
    Inventors: Lola Weiss, Vardiella Meiner, Eran Leitersdorf, Shimon Slavin, Raphael Mechoulam, Ruth Gallily, Chaim Lotan, Ronen Durst, Thea Pugatsch
  • Treating or preventing diabetes with cannabidiol
    Publication number: 20070099987
    Abstract: Use of a cannabidiol for the manufacture of a medicament identified for the treatment or prevention of diabetes and/or insulitis.
    Type: Application
    Filed: February 16, 2005
    Publication date: May 3, 2007
    Inventors: Lola Weiss, Michael Zeira, Raphael Mechoulam, Shimon Slavin, Ruth Gallily
  • Treatment for diabetes
    Patent number: 5866546
    Abstract: A composition for the treatment of diabetes and a method of use thereof. composition includes an immunoregulator, preferably Linomide, and a .beta. cell proliferative agent, preferably reg protein. The composition has been shown to be effective in both inhibiting the progression of diabetes, and reversing the course of the disease, in the NOD mouse model.
    Type: Grant
    Filed: April 18, 1997
    Date of Patent: February 2, 1999
    Assignee: Hadasit Medical Research Services and Development Company Ltd.
    Inventors: David Gross, Lola Weiss, Shimon Slavin, Hiroshi Okamoto
  • Use of quinoline-3-carboxamide compounds for treatment of diabetes
    Patent number: 5594005
    Abstract: Quinoline-3-carboxamide compounds of formula (I) are effective in preventing, treating or ameliorating Type I diabetes. ##STR1## wherein ----- represents two conjugated double bonds between the atoms comprised by the dashed line, X.sub.1 and X.sub.2 are independently selected from an oxygen atom or NH.sup.9, H.sup.1-9 independently represent a hydrogen atom or a substituent, wherein H.sup.7 and H.sup.8 are attached to different atoms selected from X.sub.1, X.sub.2 and the ring nitrogen atom of the quinoline ring. In particular, X.sub.1 and X.sub.2 being bound by a single bond to the ring when H.sup.7 or H.sup.8 is bonded thereto and by a double bond when H.sup.7 or H.sup.8 is not bonded thereto.
    Type: Grant
    Filed: December 23, 1994
    Date of Patent: January 14, 1997
    Assignee: Pharmacia AB
    Inventors: Shimon Slavin, Lola Weiss, David Gross